Hosted on MSN11mon
Optimizing tissue engineering in rotator cuff repair
R etear and failure to heal are significant post-operative complications in rotator cuff repair surgery despite the use of commercially available rotator cuff repair grafts. Advances in tissue ...
Medical Device Network on MSN14d
FDA clears Atreon’s bioresorbable synthetic implant for rotator cuff repair
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the BioCharge Autobiologic Matrix, a bioresorbable synthetic implant developed by startup Atreon Orthopedics to enhance ...
Healio1mon
Autologous dermal fibroblast injection may decrease rotator cuff retear risk
Autologous dermal fibroblasts may decrease risk of rotator cuff retears after arthroscopic rotator cuff repair vs. repair alone. Both treatments showed similar and significant improvements in ...